Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Catherine Shaffer

Showing results (11-20 of 22) with videos related to

Pageof 3
Sort By:
Drug Discovery Today|November 1, 2005
Drug discovery veers off targetCatherine Shaffer
Nature Biotechnology|October 6, 2020
Mist begins to clear for lung delivery of RNACatherine Shaffer
Nature Biotechnology|May 18, 2026
Potato pestsCatherine Shaffer
Nature Biotechnology|February 10, 2021
Trop2 deal heats up antibody-drug conjugate space in cancerCatherine Shaffer
Nature Biotechnology|December 17, 2009
FDA recruits prominent criticsCatherine Shaffer
Nature Biotechnology|March 10, 2010
US biodefense contracts continue to lure biotechsCatherine Shaffer
Nature Biotechnology|January 12, 2010
Report concludes industry-academia partnerships on the waneCatherine Shaffer
Nature Biotechnology|March 9, 2007
Incretin mimetics vie for slice of type 2 diabetes marketCatherine Shaffer
Nature Biotechnology|March 15, 2022
Broad defeats Berkeley CRISPR patentCatherine Shaffer
Psychological Assessment|November 8, 2016
Does reassessment of risk improve predictions? A framework and examination of the SAVRY and YLS/CMIJodi L Viljoen, Andrew L Gray, Catherine Shaffer, et al.
Pageof 3

Showing results (11-20 of 22) with videos related to

Sort By:
Pageof 3
Drug Discovery Today|November 1, 2005
Drug discovery veers off targetCatherine Shaffer
Nature Biotechnology|October 6, 2020
Mist begins to clear for lung delivery of RNACatherine Shaffer
Nature Biotechnology|May 18, 2026
Potato pestsCatherine Shaffer
Nature Biotechnology|February 10, 2021
Trop2 deal heats up antibody-drug conjugate space in cancerCatherine Shaffer
Nature Biotechnology|December 17, 2009
FDA recruits prominent criticsCatherine Shaffer
Nature Biotechnology|March 10, 2010
US biodefense contracts continue to lure biotechsCatherine Shaffer
Nature Biotechnology|January 12, 2010
Report concludes industry-academia partnerships on the waneCatherine Shaffer
Nature Biotechnology|March 9, 2007
Incretin mimetics vie for slice of type 2 diabetes marketCatherine Shaffer
Nature Biotechnology|March 15, 2022
Broad defeats Berkeley CRISPR patentCatherine Shaffer
Psychological Assessment|November 8, 2016
Does reassessment of risk improve predictions? A framework and examination of the SAVRY and YLS/CMIJodi L Viljoen, Andrew L Gray, Catherine Shaffer, et al.
Pageof 3